ReviewJournal of robotic surgery2025
Advanced robotic surgery in obese patients with gynecological cancers: tips and tricks from literature to clinical practice.
Review in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Obesityand Gynaecological Cancers, with a Focus on Morbid Obesity: Risk Stratification, Early Diagnosis and Management.Diagnostics (Basel, Switzerland) · 2026Review
- Port placement and patient-specific docking strategies for robotic hysterectomy with the Hugo™ RAS system: an international Delphi consensus.Facts, views & vision in ObGyn · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity is closely linked to an increased incidence of several gynecological conditions and poses significant challenges to their surgical management. Among these, endometrial cancer stands out due to its high prevalence in patients with elevated body mass index, with nearly 60% of those requiring primary surgical treatment classified as obese or morbidly obese. The coexistence of multiple comorbidities in this population contributes to a heightened risk of perioperative and postoperative complications. Robotic-assisted surgery has emerged as a key advancement in minimally invasive gynecologic procedures, offering meaningful clinical advantages over conventional laparoscopy. These include decreased intraoperative blood loss, reduced complication rates, and shorter recovery times. Such benefits are particularly advantageous in obese patients, where robotic techniques are associated with significantly lower rates of conversion to laparotomy. Nonetheless, the surgical care of these patients remains complex and requires the coordinated expertise of seasoned surgical and anesthetic teams. The aim of this review is to provide evidence-based tips and techniques for performing successful minimally invasive robotic-assisted procedures in obese patients. This paper will review current evidence on: (1) operating room setup and patient preparation; (2) robotic port placement strategies; (3) pneumoperitoneum establishment and physiological considerations; (4) intraoperative techniques and (5) practical solutions for addressing challenges in retroperitoneal staging.
Indexed as
Identifiers
40911212What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.